{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:24:11Z","timestamp":1771025051324,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Outstanding Research Start-up Fund of the People's Hospital of Zhejiang Province","award":["ZRY2020B002"],"award-info":[{"award-number":["ZRY2020B002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03237-0","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:54:28Z","timestamp":1753278868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RNF213 governs divergent tumor-immune dynamics across human cancers: a prognostic biomarker for immunotherapy stratification"],"prefix":"10.1007","volume":"16","author":[{"given":"Jinpeng","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhekuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changtian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"3","key":"3237_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6987.","journal-title":"JAMA Oncol"},{"issue":"7278","key":"3237_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature08658","volume":"463","author":"ED Pleasance","year":"2010","unstructured":"Pleasance ED, Cheetham RK, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2010;463(7278):191\u20136. https:\/\/doi.org\/10.1038\/nature08658.","journal-title":"Nature"},{"issue":"7278","key":"3237_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature08629","volume":"463","author":"ED Pleasance","year":"2010","unstructured":"Pleasance ED, Stephens PJ, O\u2019Meara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 2010;463(7278):184\u201390. https:\/\/doi.org\/10.1038\/nature08629.","journal-title":"Nature"},{"issue":"7218","key":"3237_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nature07485","volume":"456","author":"TJ Ley","year":"2008","unstructured":"Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008;456(7218):66\u201372. https:\/\/doi.org\/10.1038\/nature07485.","journal-title":"Nature"},{"issue":"11","key":"3237_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","volume":"28","author":"C Asselman","year":"2022","unstructured":"Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;28(11):939\u201350. https:\/\/doi.org\/10.1016\/j.molmed.2022.08.009.","journal-title":"Trends Mol Med"},{"key":"3237_CR6","doi-asserted-by":"publisher","first-page":"e56185","DOI":"10.7554\/eLife.56185","volume":"9","author":"J Ahel","year":"2020","unstructured":"Ahel J, Lehner A, Vogel A, et al. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism. eLife. 2020;9:e56185. https:\/\/doi.org\/10.7554\/eLife.56185.","journal-title":"eLife"},{"issue":"9","key":"3237_CR7","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.3390\/ijms23094492","volume":"23","author":"G Pollaci","year":"2022","unstructured":"Pollaci G, Gorla G, Potenza A, et al. Novel multifaceted roles for RNF213 protein. Int J Mol Sci. 2022;23(9):4492. https:\/\/doi.org\/10.3390\/ijms23094492.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3237_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340. https:\/\/doi.org\/10.1038\/jhg.2010.132.","journal-title":"J Hum Genet"},{"key":"3237_CR9","doi-asserted-by":"publisher","unstructured":"Liu W, Morito D, Takashima S et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6(7):e22542. https:\/\/doi.org\/10.1371\/journal.pone.0022542","DOI":"10.1371\/journal.pone.0022542"},{"key":"3237_CR10","doi-asserted-by":"publisher","first-page":"687088","DOI":"10.3389\/fneur.2021.687088","volume":"12","author":"Y Mineharu","year":"2021","unstructured":"Mineharu Y, Miyamoto S. RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability. Front Neurol. 2021;12:687088. https:\/\/doi.org\/10.3389\/fneur.2021.687088.","journal-title":"Front Neurol"},{"issue":"11","key":"3237_CR11","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1101\/gr.165126.113","volume":"24","author":"ZS Bao","year":"2014","unstructured":"Bao ZS, Chen HM, Yang MY, et al. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res. 2014;24(11):1765\u201373. https:\/\/doi.org\/10.1101\/gr.165126.113.","journal-title":"Genome Res"},{"issue":"7","key":"3237_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/ncb3376","volume":"18","author":"RS Banh","year":"2016","unstructured":"Banh RS, Iorio C, Marcotte R, et al. PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia. Nat Cell Biol. 2016;18(7):803\u201313. https:\/\/doi.org\/10.1038\/ncb3376.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"3237_CR13","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.7150\/thno.22010","volume":"8","author":"X Li","year":"2018","unstructured":"Li X, Xu W, Kang W, et al. Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features. Theranostics. 2018;8(6):1740\u201351. https:\/\/doi.org\/10.7150\/thno.22010.","journal-title":"Theranostics"},{"issue":"2","key":"3237_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3892\/mmr.2012.1183","volume":"7","author":"JB Zhou","year":"2013","unstructured":"Zhou JB, Zhang T, Wang BF, Gao HZ, Xu X. Identification of a novel gene fusion RNF213-SLC26A11 in chronic myeloid leukemia by RNA-Seq. Mol Med Rep. 2013;7(2):591\u20137. https:\/\/doi.org\/10.3892\/mmr.2012.1183.","journal-title":"Mol Med Rep"},{"issue":"1","key":"3237_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13073-015-0219-2","volume":"7","author":"AL Vettore","year":"2015","unstructured":"Vettore AL, Ramnarayanan K, Poore G, et al. Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance. Genome Med. 2015;7(1):98. https:\/\/doi.org\/10.1186\/s13073-015-0219-2.","journal-title":"Genome Med"},{"issue":"13","key":"3237_CR16","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.3390\/ijms241310823","volume":"24","author":"D Ban","year":"2023","unstructured":"Ban D, Housley SN, McDonald JF. The clinical significance of genetic variation in ovarian cancer. Int J Mol Sci. 2023;24(13):10823. https:\/\/doi.org\/10.3390\/ijms241310823.","journal-title":"Int J Mol Sci"},{"key":"3237_CR17","unstructured":"Ge S, Li B, Li Y, et al. Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing. Am J Cancer Res. 2017;7(7):1540\u201353."},{"issue":"2","key":"3237_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/1759-7714.13741","volume":"12","author":"N Jiang","year":"2021","unstructured":"Jiang N, Zhou J, Zhang W, et al. RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early\u2010stage lung cancer from pulmonary nodules. Thorac Cancer. 2021;12(2):181\u201393. https:\/\/doi.org\/10.1111\/1759-7714.13741.","journal-title":"Thorac Cancer"},{"key":"3237_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbrc.2022.04.007","volume":"609","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Habu T, Kim J, et al. Suppression of RNF213, a susceptibility gene for moyamoya disease, inhibits Endoplasmic reticulum stress through SEL1L upregulation. Biochem Biophys Res Commun. 2022;609:62\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.007.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"3237_CR20","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1101\/gr.122614.111","volume":"21","author":"A Schlattl","year":"2011","unstructured":"Schlattl A, Anders S, Waszak SM, Huber W, Korbel JO. Relating CNVs to transcriptome data at fine resolution: assessment of the effect of variant size, type, and overlap with functional regions. Genome Res. 2011;21(12):2004\u201313. https:\/\/doi.org\/10.1101\/gr.122614.111.","journal-title":"Genome Res"},{"issue":"2","key":"3237_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338\u2013e35415. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034.","journal-title":"Cell"},{"issue":"1","key":"3237_CR22","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"key":"3237_CR23","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, et al. IOBR: Multi-Omics Immuno-Oncology biological research to Decode tumor microenvironment and signatures. Front Immunol. 2021;12:687975. https:\/\/doi.org\/10.3389\/fimmu.2021.687975.","journal-title":"Front Immunol"},{"issue":"21","key":"3237_CR24","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307.","journal-title":"Cancer Res"},{"issue":"8045","key":"3237_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-024-08136-y","volume":"637","author":"A Bhardwaj","year":"2025","unstructured":"Bhardwaj A, Panepinto MC, Ueberheide B, Neel BG. A mechanism for hypoxia-induced inflammatory cell death in cancer. Nature. 2025;637(8045):470\u20137. https:\/\/doi.org\/10.1038\/s41586-024-08136-y.","journal-title":"Nature"},{"key":"3237_CR26","doi-asserted-by":"publisher","first-page":"216711","DOI":"10.1016\/j.canlet.2024.216711","volume":"588","author":"E Miele","year":"2024","unstructured":"Miele E, Anghileri E, Calatozzolo C, et al. Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: a multicentric retrospective study. Cancer Lett. 2024;588:216711. https:\/\/doi.org\/10.1016\/j.canlet.2024.216711.","journal-title":"Cancer Lett"},{"issue":"15","key":"3237_CR27","doi-asserted-by":"publisher","first-page":"e2025182118","DOI":"10.1073\/pnas.2025182118","volume":"118","author":"J Choi","year":"2021","unstructured":"Choi J, Manzano A, Dong W, et al. Integrated mutational landscape analysis of uterine leiomyosarcomas. Proc Natl Acad Sci. 2021;118(15):e2025182118. https:\/\/doi.org\/10.1073\/pnas.2025182118.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"3237_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41568-024-00736-0","volume":"24","author":"S Guelfi","year":"2024","unstructured":"Guelfi S, Hodivala-Dilke K, Bergers G. Targeting the tumour vasculature: from vessel destruction to promotion. Nat Rev Cancer. 2024;24(10):655\u201375. https:\/\/doi.org\/10.1038\/s41568-024-00736-0.","journal-title":"Nat Rev Cancer"},{"key":"3237_CR29","doi-asserted-by":"publisher","first-page":"100849","DOI":"10.1016\/j.drup.2022.100849","volume":"64","author":"M Huang","year":"2022","unstructured":"Huang M, Lin Y, Wang C, et al. New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects. Drug Resist Updat. 2022;64:100849. https:\/\/doi.org\/10.1016\/j.drup.2022.100849.","journal-title":"Drug Resist Updat"},{"issue":"11","key":"3237_CR30","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1093\/brain\/awad225","volume":"146","author":"F Ye","year":"2023","unstructured":"Ye F, Niu X, Liang F, et al. RNF213 loss-of-function promotes pathological angiogenesis in Moyamoya disease via the Hippo pathway. Brain J Neurol. 2023;146(11):4674\u201389. https:\/\/doi.org\/10.1093\/brain\/awad225.","journal-title":"Brain J Neurol"},{"issue":"8","key":"3237_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamacardio.2024.1483","volume":"9","author":"K Hikino","year":"2024","unstructured":"Hikino K, Koyama S, Ito K, et al. RNF213 variants, vasospastic angina, and risk of fatal myocardial infarction. JAMA Cardiol. 2024;9(8):723. https:\/\/doi.org\/10.1001\/jamacardio.2024.1483.","journal-title":"JAMA Cardiol"},{"issue":"7","key":"3237_CR32","doi-asserted-by":"publisher","first-page":"e002146","DOI":"10.1161\/JAHA.115.002146","volume":"4","author":"H Kobayashi","year":"2015","unstructured":"Kobayashi H, Matsuda Y, Hitomi T, et al. Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of Moyamoya disease, in angiogenesis in vitro and in vivo. J Am Heart Assoc. 2015;4(7):e002146. https:\/\/doi.org\/10.1161\/JAHA.115.002146.","journal-title":"J Am Heart Assoc"},{"key":"3237_CR33","doi-asserted-by":"crossref","unstructured":"Rodriguez-Meira A. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution. Nat Genet. 2023;55.","DOI":"10.1038\/s41588-023-01480-1"},{"key":"3237_CR34","doi-asserted-by":"publisher","first-page":"116646","DOI":"10.1016\/j.bcp.2024.116646","volume":"231","author":"P Garg","year":"2025","unstructured":"Garg P, Pareek S, Kulkarni P, Horne D, Salgia R, Singhal SS. Exploring the potential of TGF\u03b2 as a diagnostic marker and therapeutic target against cancer. Biochem Pharmacol. 2025;231:116646. https:\/\/doi.org\/10.1016\/j.bcp.2024.116646.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"3237_CR35","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1172\/JCI127726","volume":"129","author":"Y Wei","year":"2019","unstructured":"Wei Y, Zhao Q, Gao Z, et al. The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy. J Clin Invest. 2019;129(8):3347\u201360. https:\/\/doi.org\/10.1172\/JCI127726.","journal-title":"J Clin Invest"},{"issue":"1","key":"3237_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12766","volume":"290","author":"BA Wilky","year":"2019","unstructured":"Wilky BA. Immune checkpoint inhibitors: the linchpins of modern immunotherapy. Immunol Rev. 2019;290(1):6\u201323. https:\/\/doi.org\/10.1111\/imr.12766.","journal-title":"Immunol Rev"},{"issue":"4","key":"3237_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to Cancer therapy. Cancer Cell. 2015;27(4):450\u201361. https:\/\/doi.org\/10.1016\/j.ccell.2015.03.001.","journal-title":"Cancer Cell"},{"issue":"7637","key":"3237_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer\u2014immune set point. Nature. 2017;541(7637):321\u201330. https:\/\/doi.org\/10.1038\/nature21349.","journal-title":"Nature"},{"issue":"1","key":"3237_CR39","doi-asserted-by":"publisher","first-page":"100194","DOI":"10.1016\/j.xinn.2021.100194","volume":"3","author":"Y Ye","year":"2022","unstructured":"Ye Y, Zhang Y, Yang N, et al. Profiling of immune features to predict immunotherapy efficacy. Innov. 2022;3(1):100194. https:\/\/doi.org\/10.1016\/j.xinn.2021.100194.","journal-title":"Innov"},{"issue":"10","key":"3237_CR40","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/s41588-024-01899-0","volume":"56","author":"J Usset","year":"2024","unstructured":"Usset J, Rosendahl Huber A, Andrianova MA, et al. Five latent factors underlie response to immunotherapy. Nat Genet. 2024;56(10):2112\u201320. https:\/\/doi.org\/10.1038\/s41588-024-01899-0.","journal-title":"Nat Genet"},{"issue":"12","key":"3237_CR41","doi-asserted-by":"publisher","first-page":"e2245836","DOI":"10.1001\/jamanetworkopen.2022.45836","volume":"5","author":"ZX Liu","year":"2022","unstructured":"Liu ZX, Zhang XL, Zhao Q, et al. Whole-Exome sequencing among Chinese patients with hereditary diffuse gastric cancer. JAMA Netw Open. 2022;5(12):e2245836. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.45836.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3237_CR42","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1038\/s41467-024-50392-z","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, Zhu X, Sheng J, et al. RNF213 promotes Treg cell differentiation by facilitating K63-linked ubiquitination and nuclear translocation of FOXO1. Nat Commun. 2024;15(1):5961. https:\/\/doi.org\/10.1038\/s41467-024-50392-z.","journal-title":"Nat Commun"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03237-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03237-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03237-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:54:31Z","timestamp":1753278871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03237-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3237"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03237-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1394"}}